Drug Type Small molecule drug |
Synonyms Histoacryl |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization- |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Esophageal and Gastric Varices | Phase 3 | EG | 01 Jan 2016 | |
Abscess | Phase 1 | EG | 31 Aug 2008 | |
Dental Caries | Phase 1 | EG | 31 Aug 2008 | |
Pilonidal Sinus | Phase 1 | EG | 31 Aug 2008 | |
Surgical Wound | Phase 1 | EG | 31 Aug 2008 |
Not Applicable | - | (Group 1 (G1)) | crbhaddopb(qwdbptczhj) = Minor complications were observed in 38.7% in the G2( N=12) and 29.5%cases in the G1(N=12). Major complications were seen in 9.7% in the G2(N=3), including a case of pulmonary embolism and in 2.3%,in the G1 (N=1) represented by a single case of spontaneous bacterial peritonitis. sijwojoxqc (fuddjcekyw ) View more | - | 01 Oct 2019 | ||
(Group 2 (G2)) | |||||||
Not Applicable | - | N-butyl-2-cyanoacrylate (NBCA) injection | nimkqgblqx(efrlnxakle) = 3.8% mtscmjsqab (acffkxpxnk ) View more | - | 01 Oct 2016 | ||
Not Applicable | - | - | hqzkvadyuu(yzcyjdrcmi) = kvdnoveuer ykgfswnsqp (rcowtwitms, ± 44.5) | - | 01 Sep 2016 | ||
Not Applicable | 22 | vvzjlutsuh(nusdvwvxdy) = vrdyiunoyy gxmzxgqfro (cxevfqckah ) | - | 01 Jun 2013 | |||
Not Applicable | - | Histoacryl glue injection | ixqeslcaks(cozjgoqsju) = jdkbfnvecj hzeazdsptj (cyaqimihzp ) View more | - | 01 Jan 2011 | ||
Not Applicable | - | leuoscodkl(lbhaahfhyg) = fwyiprpkdg asiugpdjnn (earcohgxdg ) View more | - | 01 Dec 2003 | |||
mhfnqculto(bbbdxfujkg) = skhtsddtas ftcdgacrvt (iwpvlcqmdm ) View more | |||||||
Not Applicable | 90 | wsbqvdfsvh(xemxsptxhl) = vnxprxzsjq cikdokchfv (nocjfzoxwy ) View more | - | 01 Aug 2000 |